The impact of anti-HLA antibodies on unrelated cord blood transplantations

Blood

Volumn 116, Issue 15, 2010, Pages 2839-2846

  Takanashi, Minoko ^a   Atsuta, Yoshiko ^b   Fujiwara, Koki ^a   Kodo, Hideki ^c   Kai, Shunro ^d   Sato, Hiroyuki ^e   Kohsaki, Masatoshi ^f   Azuma, Hiroshi ^g   Tanaka, Hidenori ^a   Ogawa, Atsuko ^a   Nakajima, Kazunori ^a   Kato, Shunichi ^h  

^a Tokyo Red Cross Blood Center   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Tokyo Cord Blood Bank   (Japan)

^d HYOGO COLLEGE OF MEDICINE   (Japan)

^e SUWA RED CROSS HOSPITAL   (Japan)

^f Japanese Red Cross Society   (Japan)

^g JAPANESE RED CROSS SOCIETY   (Japan)

^h TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIBODY; ALLOANTIBODY; CD34 ANTIGEN; HLA ANTIGEN;

ADOLESCENT; ADULT; AGED; ANTIBODY SPECIFICITY; ARTICLE; CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEOPLASM; NEUTROPHIL; NEWBORN; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RED CROSS; RETROSPECTIVE STUDY; SCHOOL CHILD; THROMBOCYTE; BLOOD; EPIDEMIOLOGY; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; IMMUNOLOGY; JAPAN; LEUKOCYTE COUNT; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; RECURRENT DISEASE; RISK FACTOR; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD34; CHILD; CHILD, PRESCHOOL; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HLA ANTIGENS; HUMANS; INFANT; INFANT, NEWBORN; ISOANTIBODIES; JAPAN; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUTROPHILS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77957944417     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-10-249219     Document Type: Article

References (31)

1. Takahashi S, Ooi J, Tomonari A, et al. Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. Blood. 2007;109(3):1322-1330. (Pubitemid 46220686)
2. Gluckman E, Rocha V, Arcese W, et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol. 2004;32:397-407. (Pubitemid 38410917)
3. Brunstein CG, Barker JN, Weisdorf DJ, et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood. 2007;110(8):3064-3070.
4. Rocha V, Labopin M, Sanz G, et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004;351:2276-2285. (Pubitemid 39552743)
5. Laughlin MJ, Eapen M, Rubinstein P, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med. 2004;351:2265-2275. (Pubitemid 39552742)
6. Takahashi S, Iseki T, Ooi J, et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood. 2004;104:3813-3820. (Pubitemid 39564462)
7. Atsuta Y, Suzuki R, Nagamura-Inoue T, et al. Japan Cord Blood Bank Network. Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia. Blood. 2009;113(8):1631-1638.
8. Narimatsu H, Kami M, Miyakoshi S, et al. Graft failure following reduced-intensity cord blood transplantation for adult patients. Br J Haematol. 2006;132(1):36-41. (Pubitemid 43381569)
9. Mattsson J, Ringdéln O, Storb R. Graft failure after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2008;14:165-170. (Pubitemid 350286854)
10. Süsal C, Döhler B, Opelz G. Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk of graft failure. A collaborative transplant study report. Hum Immunol. 2009;70:569-573.
11. Everly MJ, Terasaki PI. Monitoring and treating posttransplant human leukocyte antigen antibodies. Hum Immunol. 2009;70:655-659.
12. Anasetti C, Amos D, Beatty PG, et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med. 1989;320:197-204. (Pubitemid 19034144)
13. Ottinger HD, Rebmann V, Pfeiffer KA, et al. Positive serum crossmatch as predictor for graft failure in HLA-mismatched allogeneic blood stem cell transplantation. Transplantation. 2002;73(8):1280-1285. (Pubitemid 34454276)
14. Gutman JA, McKinney SK, Pereira S, et al. Prospective monitoring for alloimmunization in cord blood transplantation: "virtual crossmatch" can be used to demonstrate donor-directed antibodies. Transplantation. 2009;87(3):415-418.
15. Takanashi M, Fujiwara K, Tanaka H, et al. The impact of HLA antibodies on engraftment of unrelated cord blood transplants. Transfusion. 2008;48:791-792. (Pubitemid 351430361)
16. Pei R, Wang G, Tarsitani C, et al. Simultaneous HLA class I and class II antibodies screening with flow cytometry. Human Immunol. 1998;59:313-322. (Pubitemid 28225990)
17. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 1995;15:825-828.
18. Gooley TA, Leisenring W, Crowley J, et al. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695-706. (Pubitemid 29126745)
19. Gray RJ. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141-1154.
20. Fine JP, Gray RJ. A proportional hazards model for subdistribution of a competing risk. J Am Stat Assoc. 1999;94:456-509.
21. Barge AJ, Johnson G, Witherspoon R, et al. Antibody-mediated marrow failure after allogeneic bone marrow transplantation. Blood. 1989;74(5):1477-1480. (Pubitemid 19251518)
22. Morales-Buenrostro LE, Terasaki PI, Marino-Vázquez LA, et al. "Natural" human leukocyte antigen antibodies found in no alloimmunized healthy males. Transplantation. 2008;86:1111-1115.
23. Claas FHJ, Doxiadis IIN. Human leukocyte antigen antibody detection and kidney allocation within Eurotransplant. Human Immunology. 2009;70:636-639.
24. Taylor PA, Ehrhardt MJ, Roforth MM, et al. Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients. Blood. 2007;109(3):1307-1315.
25. Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood. 2002;100:1611-1618.
26. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998;339(22):1565-1577. (Pubitemid 28536131)
27. Yazaki M, Atsuta Y, Kato K, et al. Incidence and risk factors of early bacterial infections after unrelated cord blood transplantation. Biol Blood Marrow Transplant. 2009;15:439-446.
28. Kataoka K, Yamamoto G, Nannya Y, et al. Successful engraftment following HLA-mismatched cord blood transplantation for patients with anti-HLAAbs. Bone Marrow Transplant. 2008;42(2):129-130.
29. Uchiyama M, Ikeda T. Successful engraftment following umbilical cord blood transplantation for patients with HLA antibody with or without corresponding HLA in the transplanted cord blood. Bone Marrow Transplant. 2010;45(1):199-200.
30. Fujiwara K, Shimano K, Tanaka H, et al. Application of bead array technology to simultaneous detection of human leucocyte antigen and human platelet antigen antibodies. Vox Sang. 2009;96:244-251.
31. Lubenko A, Rodi KM, Johnson AC. Screening for WBC antibodies by lymphocyte indirect immunofluorescence flow cytometry: superior to cytotoxicity and ELISA? Transfusion. 2001;41:1147-1153. (Pubitemid 32848093)